Logistics Articles

71. The Optimized Path To Innovation 12/15/2015

    Historically, medtech's primary process of uncovering the next great opportunity has been significant investment in internal R&D. But today, amazing technologies and ideas are being born out of universities, incubators, and accelerators. Corporations that have established strong relationships with these idea hotbeds will be able to more easily access breakthrough technologies early in development.

72. Emerging Areas For Medtech Outsourcing And Offshoring (And When To Go) 12/14/2015

    When deciding your outsourcing and offshoring strategy, timing and technology have everything to do with choosing the right location for your business. Here, we will delve into the current and emerging areas for both outsourcing and offshoring, discuss the specialties within each region, and review key background factors that will aid in your location decision.

73. Navigating The Post-Affordable Care Act Storm 12/11/2015

    Profit margins are thinner. Reimbursement is more complicated. Innovation must be more finely tuned. How will the medtech industry survive the storms of a post-Affordable Care Act (ACA) world?

     

74. Going GLocal: MedTech Strategies For Emerging Economies 12/10/2015

    For medtech companies to succeed in emerging economies, one strategy is to go “GLocal” — to remain global in vision, yet customize offerings according to specific unmet needs of customers in those markets. This strategy requires companies to make strategic decisions on frugal innovation and to create marketing plans for emerging economies.

75. The U.S. Peripheral Vascular Device Market: Shifting Demographics, Technological Innovation Fueling Growth 12/7/2015

    The U.S. market for peripheral vascular devices comprises an extensive portfolio of medical devices designed to treat an array of medical conditions. An aging U.S. population and medtech innovation that improves patient outcomes will be among the factors that drive steady growth in the value of the U.S. market for these through 2022.

76. Diabetes Device Innovation: Changing Current Treatment Algorithms 11/13/2015

    Diabetes affected almost 9 percent of adults globally in 2014. The prevalence of the condition results in a very large market for both drug delivery and diabetes-monitoring devices, and there is room for improvement in the treatment and management of the disease. Here, I will discuss two innovations which, upon release, will help address some of the shortcomings associated with current diabetes treatments options. 

77. The Design Controls + Risk Management Connection — Intended Use & User Needs 10/19/2015

    Design controls and risk management should flow and blend together, and it’s important to establish this flow early in product development - some companies treat them as related but separate processes, not realizing the close connection. Intended use is the gateway to user needs, design & development plan, design inputs, risk management plan, hazards, hazardous situations, and foreseeable sequence of events. 

     

78. The Rapidly Changing Catheter Ablation Device Market 10/9/2015

    As a result of the aging baby boomer population, as well as the increased rate of obesity among all age groups, the patient population requiring some form of cardiac treatment continues to increase. For these reasons, upwards of $30 billion is spent annually in the U.S. to manage various types of heart failure. Specifically, catheter ablation procedures have become a prevalent method of treating cardiac arrhythmias, and such procedures are expected to experience many changes over the next decade.

79. Financial And Regulatory Trends In China — And Their Implications For Med Device Companies 9/30/2015

    China has experienced a strong economic boom in the past 10 years, and many industries in China have benefited as a consequence. The medical device industry in China is no exception, growing at an average rate of 20 percent annually since 2009, and it is expected to reach almost RMB $300 billion (USD $45 billion) this year. However, China’s economy is expected to experience its first downturn in a number of years. We will discuss how this and other recent trends may affect the medical device industry in China, both now and in the future.

80. The Medical Device Industry's Big (And Better) Data Opportunity 9/11/2015

    It’s easy to see how the flow of data has transformed retail, revolutionized the travel industry, and upended the financial services sector. But a survey conducted by Reltio — the first research effort dedicated to the priorities and the use of data across medical device, pharma, and biotech in life sciences — indicates that the life sciences industry, and the medical device sector, specifically, has still a long way to go in truly embracing big data to improve the design, manufacture, and sales of products. So what can be done about it?